The UK government has announced a significant new initiative to accelerate drug discovery and improve patient care in the country.  

Pharma must balance creativity with transparency to rebuild trust in 2025. VML Health’s report reveals key trends shaping expectations.

The European Commission has approved a new regimen from AstraZeneca, which combines the company’s durvalumab with chemotherapy for patients with resectable NSCLC

Novo Nordisk has announced major leadership changes, with EVP Camilla Sylvest departing and Ludovic Helfgott taking on an expanded role.

From the latest news impacting the UK’s NHS to large industry acquisitions, March brought a range of impactful news.

Discover the latest pharma innovations, from needle-free vaccines to NHS data access and interactive case studies in medical education.

A gene therapy for heart failure with preserved ejection fraction (HFpEF) has shown promising early results.

This decision underscores the need for a preventative measure against the chlamydia, which affects millions worldwide.